Intellia Therapeutics, Inc.
NTLA$11.34+0.09% 1D
$7.9552-week range$28.25
Updated . Prices are snapshots and may be delayed.
Intellia Therapeutics, Inc. price chart
−10.28% over 7D
$13.21
$11.31
Oct 18
Oct 20
AI Outlook for Intellia Therapeutics, Inc.
Bearish posture- Long-term trend-12.7% vs 200-day average
- Medium-term trend-7.5% vs 50-day average
- Averages50-day below 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Intellia Therapeutics, Inc. performance
1D
+0.1%
7D
−10.0%
30D
−0.2%
90D
−0.3%
1Y
−54.2%
About Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. is a biotechnology company based in the United States, listed on NASDAQ since 2016 (ticker NTLA).
Intellia Therapeutics, Inc. market data
What is the price of Intellia Therapeutics, Inc. today?
Intellia Therapeutics, Inc. (NTLA) is at $11.34, +0.09% on the day.
What is the 52-week range of Intellia Therapeutics, Inc.?
Over the past year Intellia Therapeutics, Inc. has traded between $7.95 and $28.25. It is currently 17% of the way up that range.
Similar stocks
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
$4.16+14.0%
ESLA
Estrella Immunopharma Inc
$0.5352+72.6%
DRMA
Dermata Therapeutics, Inc. Common Stock
$0.91+18.4%
HUMA
Humacyte, Inc.
$0.4395+20.2%
IBRX
ImmunityBio, Inc.
$10.00−2.0%
SNTI
Senti Biosciences Holdings, Inc.
$0.2615+9.0%
MRNA
Moderna, Inc.
$236.50+4.9%
VSTM
Verastem, Inc.
$9.23+14.8%
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.